|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/2027 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 9/141 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 9/0053 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/146 | (2013.01) | ||
| A61K 31/4439 | (2013.01) |
| (11) | Patento numeris | 3842034 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20209559.2 |
| Europos patento paraiškos padavimo data | 2015-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-06-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 14196591 | 2014-12-05 | EP |
| (72) |
VERRECK, Geert , BE
|
| (73) |
Aragon Pharmaceuticals, Inc. ,
10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024,
US
|
| (54) | ANTICANCER COMPOSITIONS |
| ANTICANCER COMPOSITIONS |